Duramed Pharmaceuticals announced March 13 that the United States Food and Drug Administration (FDA) has approved the company's supplemental new drug application for Cenestin tablets in the 1.25 mg dosage strength. Cenestin, which was awarded FDA approval for the 0.625 mg and 0.9 mg strengths last year is Duramed's plant-derived, synthetic conjugated estrogens product for the
To continue reading this article, become a member of TheHorse.com.
It's FREE and you'll get full access to more than 20,000 articles, video, free reports & more.
